Insider Transactions Reported by 15 Insiders of RenovoRx, Inc.

Symbol
RNXT on Nasdaq
Location
Mountain View, CA

Insiders trading volume in the past year

RenovoRx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kamran Najmabadi 10%+ Owner $1,029,324 25 Aug 2021
BANK OF THE WEST 10%+ Owner $1,018,875 16 Mar 2022
Ramtin Agah Chief Medical Officer, Director $796,463 +$161,107 +25% 21 Jan 2026
Shaun Bagai Chief Executive Officer, Director $285,588 +$41,486 +17% 18 Dec 2025
Paul Manners Chief Financial Officer $24,383 25 Aug 2021
Ron Kocak VP, Controller and PAO $9,950 +$10,011 01 Jul 2025
Laurence J. Marton Director $9,924 +$10,218 01 Oct 2025
Angela Gill Nelms Chief Operating Officer $1,150 19 Jan 2024
David Diamond Director 01 Oct 2023
K. Angela Macfarlane Director 01 Oct 2025
Christopher J. Lehman Chief Financial Officer 30 Aug 2021
Robert J. Spiegel Director 01 Oct 2025
Una S. Ryan Director 01 Oct 2025
Leesa Gentry Chief Clinical Officer 01 Jul 2025
James M. Ahlers Chief Financial Officer 15 Jul 2022

Recent Insider Transactions by Companies or Individuals for RenovoRx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.